Cargando…
Clinical Failures of Linezolid and Implications for the Clinical Microbiology Laboratory
Autores principales: | Potoski, Brian A., Mangino, Julie E., Goff, Debra A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738517/ https://www.ncbi.nlm.nih.gov/pubmed/12498678 http://dx.doi.org/10.3201/eid0812.020139 |
Ejemplares similares
-
Introducing New Laboratory-Developed Molecular Methods in the Clinical Microbiology Laboratories
por: Pouladfar, Gholamreza
Publicado: (2012) -
Will Regulatory and Financial Considerations Dampen Innovation in the Clinical Microbiology Laboratory?
por: Gilligan, Peter H., et al.
Publicado: (2016) -
Clinical microbiology laboratories and COVID-19: the calm before the storm
por: M Blondeau, Joseph
Publicado: (2020) -
Laboratory Automation in the Microbiology Laboratory: an Ongoing Journey, Not a Tale?
por: Zimmermann, Stefan
Publicado: (2021) -
Therapeutic drug monitoring: linezolid too?
por: Richards, Guy A, et al.
Publicado: (2014)